GlaxoSmithKline settles for $105 million
GlaxoSmithKline settles for $105 million over label dispute with 45 states. GlaxoSmithKline has agreed to pay $105 million to 45
Read MoreFaulty Pharmaceutical Drugs Resources
GlaxoSmithKline settles for $105 million over label dispute with 45 states. GlaxoSmithKline has agreed to pay $105 million to 45
Read MorePregnant women who take selective serotonin reuptake inhibitors (SSRIs) may be putting their babies at risk for heart defects. SSRIs,
Read MoreSelective serotonin reuptake inhibitors (also known as SSRIs) have been linked to various birth defects in infants whose mothers took
Read MoreBirth defects are caused by a number of different factors, some more controllable than others. While some birth defects are
Read More